![Lorenzo M. Tallarigo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lorenzo M. Tallarigo
Directeur/Membre du Conseil chez
University of Indianapolis
Profil
Lorenzo M.
Tallarigo is currently a Director at Angelini Holding SRL and Angelini Holding.
SpA. He is also a Trustee at the University of Indianapolis since 2013.
Previously, he served as the Chief Executive Officer at Genextra SpA from 2009 to 2012.
From 2016 to 2020, he was the Non-Executive Chairman at Oxford Biomedica Plc.
He also served as the Chairman at EryDel SpA and as an Independent Director at Intercept Pharmaceuticals, Inc. from 2013 to 2014.
Additionally, he was a Director at Tethis SpA. Prior to these roles, he held the position of President-Intercontinental Operations at Eli Lilly & Co. from 1985 to 2008.
Dr. Tallarigo holds a doctorate degree from the University of Pisa and a doctorate degree from Harvard Business School.
Postes actifs de Lorenzo M. Tallarigo
| Sociétés | Poste | Début |
|---|---|---|
University of Indianapolis
 University of Indianapolis Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 05/08/2009 |
Angelini Holding SRL | Directeur/Membre du Conseil | 01/01/2019 |
Angelini Holding SpA
 Angelini Holding SpA Financial ConglomeratesFinance Operates as a holding company that manages equity investments in healthcare, consumer and industrial technology sectors | Directeur/Membre du Conseil | 01/01/2019 |
Anciens postes connus de Lorenzo M. Tallarigo
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Président | 23/06/2020 |
| INTERCEPT PHARMACEUTICALS, INC. | Président | 18/10/2013 |
| ELI LILLY AND COMPANY | Directeur des opérations | - |
EryDel SpA
 EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Président | - |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Develops nanostructured thin layers for biosensor | Président | - |
Formation de Lorenzo M. Tallarigo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Indianapolis
University of Indianapolis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pisa
 University of Pisa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra invest in companies located Italy. The firm focuses on the life science companies. It participates in early stage capital transactions. | Finance |
EryDel SpA
EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Health Technology |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Develops nanostructured thin layers for biosensor | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angelini Holding SRL | |
Angelini Holding SpA
Angelini Holding SpA Financial ConglomeratesFinance Operates as a holding company that manages equity investments in healthcare, consumer and industrial technology sectors | Finance |
